Erik S G Stroes Selected Research

Erik S G Stroes Research Topics

Disease

71	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2002
45	Atherosclerosis 02/2024 - 03/2004
37	Inflammation (Inflammations) 01/2024 - 04/2005
27	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 10/2004
25	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2024 - 12/2002
16	Atherosclerotic Plaque (Atheroma) 01/2024 - 02/2006
11	Aortic Valve Stenosis (Aortic Stenosis) 03/2023 - 01/2019
10	Myocardial Infarction 12/2023 - 02/2012
10	Neoplasms (Cancer) 11/2023 - 07/2007
8	Hypercholesterolemia 11/2023 - 04/2007
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2009
7	Pancreatitis 04/2024 - 03/2018
7	Type 2 Diabetes Mellitus (MODY) 11/2023 - 11/2007
7	Coronary Disease (Coronary Heart Disease) 10/2020 - 12/2009
6	Stroke (Strokes) 12/2023 - 02/2012
6	Rheumatoid Arthritis 01/2022 - 06/2007
6	Injection Site Reaction 01/2021 - 08/2007
5	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 04/2024 - 01/2019
5	Pathologic Constriction (Stenosis) 02/2024 - 09/2005
5	Hypertension (High Blood Pressure) 10/2022 - 12/2001
4	Inborn Genetic Diseases (Disease, Hereditary) 04/2024 - 01/2019
4	Hypertriglyceridemia 02/2024 - 12/2014
4	Aortic Valve Disease 11/2023 - 01/2020
4	Homozygous Familial Hypercholesterolemia 07/2023 - 08/2013
4	Disease Progression 01/2023 - 01/2019
4	Body Weight (Weight, Body) 12/2020 - 05/2007
4	Carotid Artery Diseases 10/2020 - 04/2008
4	Obesity 09/2018 - 09/2008
4	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 12/2014 - 06/2003
4	Hyperplasia 09/2005 - 02/2004
3	Hypotension (Low Blood Pressure) 11/2023 - 10/2007
3	Hyperlipoproteinemia Type III (Broad Beta Disease) 09/2023 - 01/2017
3	Dyslipidemias (Dyslipidemia) 02/2023 - 07/2007
3	Hereditary Angioedemas 01/2023 - 12/2008
3	Peripheral Arterial Disease 01/2022 - 12/2013
3	Arteritis 01/2021 - 10/2014
3	Chronic Disease (Chronic Diseases) 01/2020 - 12/2012
3	Insulin Resistance 10/2017 - 07/2007
3	Thrombosis (Thrombus) 08/2016 - 07/2009
3	Vascular Diseases (Vascular Disease) 01/2013 - 07/2007
2	Ischemia 02/2024 - 12/2001
2	Ischemic Stroke 12/2021 - 01/2021
2	Chronic Renal Insufficiency 01/2021 - 01/2017
2	Angioedema 01/2020 - 04/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 04/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2019 - 06/2007

Drug/Important Bio-Agent (IBA)

37	LipidsIBA 01/2024 - 06/2004
36	LDL CholesterolIBA 04/2024 - 06/2004
36	Lipoprotein(a)IBA 01/2024 - 06/2004
27	oxidized low density lipoproteinIBA 01/2024 - 02/2007
27	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 12/2002
23	Triglycerides (Triacylglycerol)IBA 04/2024 - 06/2004
23	HDL CholesterolIBA 11/2023 - 06/2004
17	CholesterolIBA 01/2024 - 06/2004
17	Lipoproteins (Lipoprotein)IBA 09/2023 - 06/2004
15	Biomarkers (Surrogate Marker)IBA 03/2023 - 12/2002
14	C-Reactive ProteinIBA 03/2023 - 06/2004
11	Apolipoproteins B (ApoB)IBA 01/2021 - 05/2007
11	ApolipoproteinsIBA 01/2019 - 05/2007
9	HDL LipoproteinsIBA 12/2022 - 05/2007
9	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 10/2004
8	LDL Lipoproteins (beta Lipoproteins)IBA 11/2023 - 02/2007
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2010
6	ISIS 304801IBA 02/2024 - 01/2019
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 10/2016
6	mipomersenIBA 11/2014 - 05/2010
5	Apolipoprotein C-IIIIBA 04/2024 - 12/2014
5	evolocumabIBA 09/2023 - 10/2017
5	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 06/2004
5	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 08/2016
4	omega-Chloroacetophenone (Mace)IBA 02/2024 - 10/2020
4	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2024 - 11/2005
4	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2023 - 01/2019
4	Simvastatin (Zocor)FDA LinkGeneric 04/2015 - 12/2002
4	Polytetrafluoroethylene (Teflon)FDA Link 09/2005 - 02/2004
3	CytokinesIBA 01/2024 - 01/2018
3	lipoprotein cholesterolIBA 11/2023 - 10/2007
3	evinacumabIBA 11/2023 - 12/2020
3	Atorvastatin (Lipitor)FDA Link 11/2023 - 10/2016
3	Monoclonal AntibodiesIBA 09/2023 - 01/2020
3	Blood Proteins (Serum Proteins)IBA 01/2023 - 11/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2012
3	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2015
3	CalciumIBA 01/2020 - 03/2012
3	Apolipoprotein B-100 (Apo B 100)IBA 01/2019 - 05/2010
3	EndotoxinsIBA 01/2018 - 05/2007
3	Cholesterol Ester Transfer ProteinsIBA 07/2009 - 09/2005
2	InflammasomesIBA 01/2024 - 11/2020
2	Proprotein Convertase 9IBA 09/2023 - 01/2019
2	InterleukinsIBA 01/2022 - 03/2014
2	Chemokine ReceptorsIBA 01/2021 - 03/2018
2	Ezetimibe (Zetia)FDA Link 01/2021 - 04/2008
2	CER-001IBA 10/2020 - 01/2016
2	Butyrates (Butyrate)IBA 01/2020 - 01/2016

Therapy/Procedure

43	Therapeutics 04/2024 - 12/2002
4	Blood Component Removal (Apheresis) 10/2022 - 10/2014
4	Renal Dialysis (Hemodialysis) 07/2009 - 02/2004
3	Injections 02/2024 - 01/2014
2	Diet Therapy (Therapy, Diet) 02/2024 - 02/2023
2	Drug Therapy (Chemotherapy) 11/2023 - 09/2010